Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | HD105 |
Trade Name | |
Synonyms | |
Drug Descriptions |
HD105 is a bi-specific antibody that targets VEGF and DLL4, resulting in decreased ligand-receptor binding and potentially leading to reduced tumor progression (PMID: 27049350). |
DrugClasses | DLL4 Antibody 7 VEGF Antibody 11 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HD105 | HD105 | 0 | 0 |